CUSIP: 72942A107
Q3 2022 13F Holders as of 30 Sep 2022
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
6,329,435
-
Share change
-
-1,661,193
-
Total reported value
-
$4,110,992
-
Put/Call ratio
-
0%
-
Price per share
-
$0.65
-
Number of holders
-
35
-
Value change
-
-$2,220,076
-
Number of buys
-
11
-
Number of sells
-
20
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q4 2022
-
Previous quarter:
Q2 2022
Recent filing periods for CUSIP 72942A107:
Institutional Holders of PLX PHARMA INC - COM (PLXPQ) as of Q3 2022
As of 30 Sep 2022,
PLX PHARMA INC - COM (PLXPQ) was held by
35 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
6,329,435 shares.
The largest 10 holders included
Park West Asset Management LLC, MSD Partners, L.P., VANGUARD GROUP INC, BlackRock Inc., GEODE CAPITAL MANAGEMENT, LLC, MORGAN STANLEY, TWO SIGMA ADVISERS, LP, GREEN SQUARE CAPITAL ADVISORS LLC, Federation des caisses Desjardins du Quebec, and UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGMENT CO.
This page lists
35
institutional shareholders reporting positions in this security
for the Q3 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.